189 related articles for article (PubMed ID: 17557121)
21. Gene transfer of antisense hypoxia inducible factor-1 alpha enhances the therapeutic efficacy of cancer immunotherapy.
Sun X; Kanwar JR; Leung E; Lehnert K; Wang D; Krissansen GW
Gene Ther; 2001 Apr; 8(8):638-45. PubMed ID: 11320410
[TBL] [Abstract][Full Text] [Related]
22. In vivo enhancement of angiogenesis by adenoviral transfer of HIF-1alpha-modified endothelial progenitor cells (Ad-HIF-1alpha-modified EPC for angiogenesis).
Jiang M; Wang B; Wang C; He B; Fan H; Shao Q; Gao L; Liu Y; Yan G; Pu J
Int J Biochem Cell Biol; 2008; 40(10):2284-95. PubMed ID: 18450499
[TBL] [Abstract][Full Text] [Related]
23. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.
Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM
Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816
[TBL] [Abstract][Full Text] [Related]
24. Evaluating hypoxia-inducible factor-1alpha as a cancer therapeutic target via inducible RNA interference in vivo.
Li L; Lin X; Staver M; Shoemaker A; Semizarov D; Fesik SW; Shen Y
Cancer Res; 2005 Aug; 65(16):7249-58. PubMed ID: 16103076
[TBL] [Abstract][Full Text] [Related]
25. Canstatin gene electrotransfer combined with radiotherapy: preclinical trials for cancer treatment.
Magnon C; Opolon P; Connault E; Mir LM; Perricaudet M; Martel-Renoir D
Gene Ther; 2008 Nov; 15(21):1436-45. PubMed ID: 18548116
[TBL] [Abstract][Full Text] [Related]
26. HIF-1 and NDRG2 contribute to hypoxia-induced radioresistance of cervical cancer Hela cells.
Liu J; Zhang J; Wang X; Li Y; Chen Y; Li K; Zhang J; Yao L; Guo G
Exp Cell Res; 2010 Jul; 316(12):1985-93. PubMed ID: 20206160
[TBL] [Abstract][Full Text] [Related]
27. Radiation-induced mitotic cell death and glioblastoma radioresistance: a new regulating pathway controlled by integrin-linked kinase, hypoxia-inducible factor 1 alpha and survivin in U87 cells.
Lanvin O; Monferran S; Delmas C; Couderc B; Toulas C; Cohen-Jonathan-Moyal E
Eur J Cancer; 2013 Sep; 49(13):2884-91. PubMed ID: 23747271
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial activation by inhibition of PDKII suppresses HIF1a signaling and angiogenesis in cancer.
Sutendra G; Dromparis P; Kinnaird A; Stenson TH; Haromy A; Parker JM; McMurtry MS; Michelakis ED
Oncogene; 2013 Mar; 32(13):1638-50. PubMed ID: 22614004
[TBL] [Abstract][Full Text] [Related]
29. The radiation dose-regulated AND gate genetic circuit, a novel targeted and real-time monitoring strategy for cancer gene therapy.
Ding M; Zhang E; He R; Wang X; Li R; Wang W; Yi Q
Cancer Gene Ther; 2012 Jun; 19(6):382-92. PubMed ID: 22498721
[TBL] [Abstract][Full Text] [Related]
30. Eicosanoids and other lipid mediators and the tumor hypoxic microenvironment.
Krishnamoorthy S; Honn KV
Cancer Metastasis Rev; 2011 Dec; 30(3-4):613-8. PubMed ID: 22042480
[TBL] [Abstract][Full Text] [Related]
31. Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy.
Meijer TW; Kaanders JH; Span PN; Bussink J
Clin Cancer Res; 2012 Oct; 18(20):5585-94. PubMed ID: 23071360
[TBL] [Abstract][Full Text] [Related]
32. Canstatin: an inhibitor of angiogenesis and tumor growth revisited.
Narazaki M; Tosato G
Cancer J; 2006; 12(2):110-2. PubMed ID: 16630401
[No Abstract] [Full Text] [Related]
33. Silencing of HIF-1α enhances the radiation sensitivity of human glioma growth in vitro and in vivo.
Luo Z; Bai M; Xiao X; Zhang W; Liu X; Yang X; Li S; Huan Y; Wu Z; Zhang X; Cao W
Neuropharmacology; 2015 Feb; 89():168-74. PubMed ID: 24859610
[TBL] [Abstract][Full Text] [Related]
34. HIFs, angiogenesis, and cancer.
Yang Y; Sun M; Wang L; Jiao B
J Cell Biochem; 2013 May; 114(5):967-74. PubMed ID: 23225225
[TBL] [Abstract][Full Text] [Related]
35. HIF-1 Alpha Regulates the Response of Primary Sarcomas to Radiation Therapy through a Cell Autonomous Mechanism.
Zhang M; Qiu Q; Li Z; Sachdeva M; Min H; Cardona DM; DeLaney TF; Han T; Ma Y; Luo L; Ilkayeva OR; Lui K; Nichols AG; Newgard CB; Kastan MB; Rathmell JC; Dewhirst MW; Kirsch DG
Radiat Res; 2015 Jun; 183(6):594-609. PubMed ID: 25973951
[TBL] [Abstract][Full Text] [Related]
36. Functional expression of recombinant canstatin in stably transformed Drosophila melanogaster S2 cells.
Lee JM; Jeon HB; Sohn BH; Chung IS
Protein Expr Purif; 2007 Apr; 52(2):258-64. PubMed ID: 17208009
[TBL] [Abstract][Full Text] [Related]
37. Transcutaneous carbon dioxide enhances the antitumor effect of radiotherapy on oral squamous cell carcinoma.
Iwata E; Hasegawa T; Ueha T; Takeda D; Saito I; Kawamoto T; Akisue T; Sakai Y; Sasaki R; Kuroda R; Komori T
Oncol Rep; 2018 Jul; 40(1):434-442. PubMed ID: 29767262
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia-inducible factor 1-mediated characteristic features of cancer cells for tumor radioresistance.
Harada H
J Radiat Res; 2016 Aug; 57 Suppl 1(Suppl 1):i99-i105. PubMed ID: 26983985
[TBL] [Abstract][Full Text] [Related]
39. Canstatin induces apoptosis in gastric cancer xenograft growth in mice through the mitochondrial apoptotic pathway.
Xing YN; Deng P; Xu HM
Biosci Rep; 2014 Apr; 34(2):. PubMed ID: 27919040
[TBL] [Abstract][Full Text] [Related]
40. Overcoming Radioresistance in Tumor Therapy by Alleviating Hypoxia and Using the HIF-1 Inhibitor.
Zhou X; Liu H; Zheng Y; Han Y; Wang T; Zhang H; Sun Q; Li Z
ACS Appl Mater Interfaces; 2020 Jan; 12(4):4231-4240. PubMed ID: 31912727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
